Last reviewed · How we verify
Air O2
Air O2 is a portable oxygen delivery system that provides supplemental oxygen therapy to patients with respiratory insufficiency.
Air O2 is a portable oxygen delivery system that provides supplemental oxygen therapy to patients with respiratory insufficiency. Used for Chronic obstructive pulmonary disease (COPD), Hypoxemia requiring supplemental oxygen therapy.
At a glance
| Generic name | Air O2 |
|---|---|
| Sponsor | University College, London |
| Modality | Small molecule |
| Therapeutic area | Respiratory/Pulmonology |
| Phase | FDA-approved |
Mechanism of action
Air O2 is a marketed medical device rather than a pharmaceutical drug, designed to deliver oxygen to patients who require respiratory support. It functions as an oxygen concentrator or portable oxygen system that extracts and concentrates oxygen from ambient air for therapeutic inhalation.
Approved indications
- Chronic obstructive pulmonary disease (COPD)
- Hypoxemia requiring supplemental oxygen therapy
Common side effects
Key clinical trials
- Exercise and Carotid Artery Function in Metabolic Syndrome
- Combination Therapy to Improve SCI Recovery. (NA)
- Low Oxygen Therapy to Enhance Walking Recovery After SCI. (NA)
- Investigating the Effects of Intermittent Hypoxia-Hyperoxia Treatment (IHHT) in People With Post-Viral Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) to Improve Fatigue, Pain, and Quality of Life by Targeting Mitochondrial Dysfunction and Autonomic Nervous System Impairment (NA)
- Hand Perfusion and Pulse Oximetry Performance
- Fatigue and Skeletal Muscle Impact in Severe Axial Spondyloarthritis (NA)
- The Effect of Hypercapnia on Physiological Parameters During Short-term Breathing (NA)
- General Anesthesia and General Anesthesia Combined With Thoracic Epidural Anesthesia (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Air O2 CI brief — competitive landscape report
- Air O2 updates RSS · CI watch RSS
- University College, London portfolio CI